Blue Owl slashes Loparex loan valuation as bankruptcy risk mounts
Blue Owl Capital has sharply reduced the value of its loans to specialty materials manufacturer Loparex, highlighting renewed concerns over credit quality and valuation practices across the $1.8tn private credit market, according to a report by Bloomberg.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.